375 related articles for article (PubMed ID: 28807659)
1. Expanding state laws and a growing role for pharmacists in vaccination services.
Schmit CD; Penn MS
J Am Pharm Assoc (2003); 2017; 57(6):661-669. PubMed ID: 28807659
[TBL] [Abstract][Full Text] [Related]
2. Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents?
Trogdon JG; Shafer PR; Shah PD; Calo WA
Vaccine; 2016 Aug; 34(38):4514-4519. PubMed ID: 27496275
[TBL] [Abstract][Full Text] [Related]
3. Authority of Pharmacists to Administer Human Papillomavirus Vaccine: Alignment of State Laws With Age-Level Recommendations.
Dingman DA; Schmit CD
Public Health Rep; 2018; 133(1):55-63. PubMed ID: 29257933
[TBL] [Abstract][Full Text] [Related]
4. An update on community pharmacies as CLIA-waived facilities.
Adams AJ; Klepser ME; Klepser D
Res Social Adm Pharm; 2016; 12(4):666-7. PubMed ID: 27138067
[No Abstract] [Full Text] [Related]
5. Encouraging comprehensive and consistent pharmacist education for provision of contraception.
Anderson L; Borgelt LM; Clark P; Moore G
J Am Pharm Assoc (2003); 2018; 58(1):113-116. PubMed ID: 29290339
[TBL] [Abstract][Full Text] [Related]
6. Pharmacists' Patient Care Process: State "Scope of Practice" Priorities for Action.
Adams AJ; Weaver KK
Ann Pharmacother; 2021 Apr; 55(4):549-555. PubMed ID: 32787618
[TBL] [Abstract][Full Text] [Related]
7. Ending tobacco sales in pharmacies: A qualitative study.
Jin Y; Berman M; Klein EG; Foraker RE; Lu B; Ferketich AK
J Am Pharm Assoc (2003); 2017; 57(6):670-676.e1. PubMed ID: 28823544
[TBL] [Abstract][Full Text] [Related]
8. Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges.
Taitel MS; Fensterheim LE; Cannon AE; Cohen ES
Am J Manag Care; 2013 Sep; 19(9):e309-13. PubMed ID: 24449960
[TBL] [Abstract][Full Text] [Related]
9. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
Svensberg K; Sporrong SK; Björnsdottir I
Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
[TBL] [Abstract][Full Text] [Related]
10. Finance issue brief: any willing provider: year end report-2002.
Morgan R; MacEachern L
Issue Brief Health Policy Track Serv; 2002 Dec; ():1-10. PubMed ID: 12884878
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention.
Brewer NT; Chung JK; Baker HM; Rothholz MC; Smith JS
Gynecol Oncol; 2014 Mar; 132 Suppl 1():S3-8. PubMed ID: 24361732
[TBL] [Abstract][Full Text] [Related]
12. A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
McConeghy KW; Wing C
Vaccine; 2016 Jun; 34(30):3463-8. PubMed ID: 27219340
[TBL] [Abstract][Full Text] [Related]
13. Community pharmacy-based injectable naltrexone service delivery models and best practices.
Ford JH; Gilson AM; Bryan G; Augustine C; Gassman M; Mott DA
Res Social Adm Pharm; 2021 Jul; 17(7):1332-1341. PubMed ID: 33268242
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.
Hattingh HL; Sim TF; Parsons R; Czarniak P; Vickery A; Ayadurai S
BMJ Open; 2016 Sep; 6(9):e011948. PubMed ID: 27650763
[TBL] [Abstract][Full Text] [Related]
15. Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization.
Kumar A; Ray AB; Blanchard C
Health Res Policy Syst; 2022 Jan; 20(1):1. PubMed ID: 34980147
[TBL] [Abstract][Full Text] [Related]
16. Accessibility of adult immunizations in pharmacies compared to physician offices in low-income communities.
Popovian R; Winegarden W; Rivera E; Gavigan K
J Am Pharm Assoc (2003); 2022; 62(5):1644-1647. PubMed ID: 35491381
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
Skelton JB; ;
J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
[TBL] [Abstract][Full Text] [Related]
18. Emerging Developments in Pharmacists' Scope of Practice to Address Unmet Health Care Needs.
Burns AL
Ann Pharmacother; 2016 Sep; 50(9):785-7. PubMed ID: 27340143
[TBL] [Abstract][Full Text] [Related]
19. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
Pojskic N; MacKeigan L; Boon H; Austin Z
Res Social Adm Pharm; 2014; 10(2):341-54. PubMed ID: 23816494
[TBL] [Abstract][Full Text] [Related]
20. Impact of pharmacist administration of influenza vaccines on uptake in Canada.
Buchan SA; Rosella LC; Finkelstein M; Juurlink D; Isenor J; Marra F; Patel A; Russell ML; Quach S; Waite N; Kwong JC;
CMAJ; 2017 Jan; 189(4):E146-E152. PubMed ID: 27503864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
